Skip to content

Comparison of two clinical monitoring strategies in patients with a new left bundle branch block after transcatheter aortic valve implantation (TAVI)

Left bundle branch block (LBBB) is one of the most common complications after patients having the transcatheter aortic valve implantation (TAVI). However, there is no specific guidelines for management of patients with new onset LBBB. The purpose of the study is to determine which clinical management approach has better clinical outcomes to treat a LBBB after TAVI. This study will look at an electrophysiology-based monitoring approach or a follow-up with 30-day transcutaneous cardiac monitor. Participants will be assigned by chance to one of the two methods and then be followed up at 1 month, 3 month, and 12 month by phone or on-site. 

null

Participation Requirements

  • Sex:

    Any

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:
1. Age ≥18 years
2. Informed consent to participate
3. Persistent new-onset LBBB after TAVI implantation (i.e. present at day 2).
Exclusion Criteria:
1. Prior pacemaker or implantable cardioverter-defibrillator
2. Pre-existing right bundle branch block (RBBB) or LBBB (i.e., prior to TAVI)
3. Class I or IIA indication for PPM implantation according to management guidelines

Study Location

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Study Sponsored By
University of Alberta
Participants Required
More Information
Study ID: Pro00112658